Rebecca Cohen

Investor Relations Contact chez IKENA ONCOLOGY, INC.

Health Technology

Consumer Services

Postes actifs de Rebecca Cohen

Sociétés	Poste	Début	Fin
IKENA ONCOLOGY, INC.	Investor Relations Contact	-	-

Sociétés	Poste	Début	Fin
SQZ BIOTECHNOLOGIES COMPANY	Investor Relations Contact	01/01/2017	01/07/2018
SQZ BIOTECHNOLOGIES COMPANY	Public Communications Contact	01/01/2017	01/07/2018
EPIZYME, INC.	Public Communications Contact	-	01/05/2016
Jewish Big Brothers Big Sisters of Greater Boston	Directeur/Membre du Conseil	-	-
Solomon Schechter Day School of Greater Boston	Directeur/Membre du Conseil	-	-
MESOBLAST LIMITED	Directeur Technique/Scientifique/R&D	-	-

Rutgers State University of New Jersey

Undergraduate Degree

Internationale

Etats-Unis	7
Australie	2

Opérationnelle

Public Communications Contact	2
Investor Relations Contact	2
Director/Board Member	2

Sectorielle

Health Technology	5
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	3
SQZ BIOTECHNOLOGIES COMPANY	Health Technology
MESOBLAST LIMITED	Health Technology
IKENA ONCOLOGY, INC.	Health Technology

Entreprise privées	3
Epizyme, Inc. Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA.	Health Technology
Jewish Big Brothers Big Sisters of Greater Boston
Solomon Schechter Day School of Greater Boston